Table 6.
Genomics funding per GDP by country (×100,000)
| Rank | Country | 2003 | 2004 | 2005 | 2006 |
| 1 | Ireland | 27.27 | 24.44 | 18.61 | 17.48 |
| 2 | United Kingdom | 19.25 | 17.02 | 17.24 | 15.55 |
| 3 | Canada | 14.38 | 12.37 | 11.34 | 13.06 |
| 4 | United States | 9.34 | 9.09 | 8.42 | 7.81 |
| 5 | Netherlands | 9.04 | 2.98 | 8.21 | 6.91 |
| 6 | South Korea | 6.53 | 5.15 | 5.27 | 5.05 |
| 7 | Japan | 2.72 | 3.06 | 3.49 | 3.62 |
| 8 | China | 4.88 | 4.14 | 3.58 | 0.00* |
| 9 | Germany | 2.93 | 2.24 | 2.22 | 2.24 |
| 10 | South Africa | 1.44 | 1.12 | 1.27 | 0.87* |
| 11 | Australia | 1.43 | 1.00 | 0.88 | 1.03 |
| 12 | Spain | 1.13 | 1.16 | 1.20 | 0.96 |
The amount of genomics research funded per GDP by each country or region is indicated in US$ (× 100,000 for ease of comparison). Rankings were determined by ordering the 2006 values, where the average of the three previous years was used as a substitute for 2006 values when the actual 2006 data was unavailable. Data is reported by fiscal year, as indicated in Table 1.
* The 2006 data is incomplete because of missing information from the South African National Research Foundation or from China's research organizations.